Drug-labels.com

PMS-Ipratropium (Pharmascience, 21 mcg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
21 mcg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - PMS-Ipratropium (Pharmascience, 21 mcg)

ABOUT THIS MEDICATION

What the medication is used for:

pms-IPRATROPIUM nasal spray 0.03% is used to treat the runny nose associated with perennial allergic or nonallergic rhinitis.

pms-IPRATROPIUM nasal spray is intended to relieve your rhinorrhea (runny nose) with regular use. It is therefore important that you use pms-IPRATROPIUM nasal spray as prescribed by your physician. Some improvement in rhinorrhea is usually apparent during the first full day of treatment with pms-IPRATROPIUM nasal spray.

However, maximum benefit may not occur for up to several weeks after treatment has started.

What it does:

pms-IPRATROPIUM nasal spray works to stop the glands in your nose from producing excessive nasal secretions. pms-IPRATROPIUM nasal spray must be prescribed by a doctor.

When it should not be used:

Nasal spray should not be used by patients with a history of allergy to ipratropium bromide, or to any component of this formulation.

pms-IPRATROPIUM nasal spray should not be used by patients with allergic reaction to ipratropium bromide, atropinics (atropine or atropine-like drugs) or to any component of the drug (See What the nonmedicinal ingredients are)

What the medicinal ingredient is:

Ipratropium bromide

What the nonmedicinal ingredients are:

Benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, sodium hydroxide and purified water.

What dosage forms it comes in:

Nasal Spray: 0.03% w/v

WARNINGS AND PRECAUTIONS

BEFORE you use pms-IPRATROPIUM talk to your doctor or pharmacist if:

$ you are pregnant or intend to become pregnant; $ you are breast feeding;

$ you have any other health problems, now or in the past; $ you have eye problems, such as predisposition to glaucoma; $ you have difficulty/trouble urinating or problems with your prostate;

$ you are taking any other medications including eye drops or any medications you can buy without prescription; $ you have any allergies or reactions to foods or drugs.

pms-IPRATROPIUM Nasal Spray may cause dizziness, difficulty in focusing the eyes, dilated pupils, and blurred vision. You should not drive or operate machinery if this occurs.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with pms-IPRATROPIUM nasal spray include: Other anticholinergic drugs.

PROPER USE OF THIS MEDICATION

Usual dose:

1.

Remove the clear plastic dust cap and the safety clip from the nasal spray pump. The safety clip prevents the accidental discharge of the spray in your pocket or purse.

2.The nasal spray pump must be primed before pms-

IPRATROPIUM nasal spray is used for the first time. To prime the pump, hold the bottle with your thumb at the base and your index and middle fingers on the white shoulder area. Make sure the bottle points upright and away from your eyes. Press your thumb firmly and quickly against the bottle seven times. The pump is now primed and can be used. Your pump should not have to be reprimed unless you have not used

the medication for more than 24 hours; repriming the pump will only require one or two sprays.

3 Before using pms-IPRATROPIUM nasal spray, blow your

nose gently to clear your nostrils if necessary.

  1. 4. Close one nostril by gently placing your finger against the side of your nose, tilt your head slightly forward and, keeping the bottle upright, insert the nasal tip into the other nostril. Point the tip toward the back and outer side of the nose.
  2. 5.

    Press firmly and quickly upwards with the thumb at the base

    while holding the white shoulder portion of the pump between your index and middle fingers. Following each spray, sniff deeply and breathe out through your mouth.

  3. 6.

    After spraying the nostril and removing the unit, tilt your head

    backwards for a few seconds to let the spray spread over the back of the nose.

  4. 7. Repeat steps 4 through 6 in the other nostril.
  5. 8. Replace the clear plastic dust cap and safety clip.
  6. 9.

    When the amount of pms-IPRATROPIUM nasal spray begins

    to run low, the amount of medication in each spray cannot be assured. Therefore, at some time before the medication is completely used up, you should consult your physician or pharmacist to determine whether a refill is needed. You should not take extra doses of pms-IPRATROPIUM nasal spray without consulting your physician.

To Clean:

If the nasal tip becomes

clogged, remove the

clear plastic dust cap and

safety clip. Hold the

nasal tip under running

warm tap water for about

a minute. Dry the nasal

tip, reprime the nasal

spray pump (step 2

above), and replace the

plastic dust cap and

safety clip.

Avoid spraying pms-IPRATROPIUM nasal spray in or around your eyes. Should this occur, immediately flush your eyes with cool tap water for several minutes. If you accidentally spray pms-IPRATROPIUM nasal spray in your eyes, you may experience a temporary blurring of vision and increased

sensitivity to light, which may last a few hours.

Do not exceed the number of sprays, or the length of use, prescribed by your doctor.

pms-IPRATROPIUM nasal spray has been prescribed to treat your current condition. Do not give it to other people.

Do not take other medication without your doctor’s advice.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Center immediately, even if there are no symptoms. Always take the labeled medicine container with you.

Missed Dose:

If you forget to take your dose, don’t worry. Take your next dose as usual. Do not double your dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like any other drug product, pms-IPRATROPIUM nasal spray may cause unwanted effects along with its good effects. If you do experience any of the unwanted effects listed below, you should contact your doctor. He/she may recommend that you lower your dose of pms-IPRATROPIUM nasal spray.

The most frequent side effects are headache, throat irritation, nasal discomfort, nasal dryness and nosebleeds.

Other side effects include: increased heart rate and a feeling that your heart is beating fast, heart problems such as fast or irregular heart beat ; eye disorders such as difficulty in focusing the eyes, seeing halos, swelling of the cornea, build up or increased pressure in the eye, dilated pupils, swelling of the blood vessels in the conjunctiva (outermost layer of the eye and inner surface of the eyelids), blurred vision, eye pain; difficulty in passing urine; swelling of the muscles around the voice box; dry throat, dry mouth, swelling of the mouth and throat, increased wheezing or tightness in the chest or difficulty in breathing (bronchospasm) ; digestive problems like constipation, diarrhoea and vomiting; dizziness.

Some people can be allergic to medicines. If you have any of the following symptoms soon after taking pms-IPRATROPIUM nasal spray, stop taking this medicine and tell your doctor immediately or go the nearest hospital:

$ Sudden wheeziness and chest pain or tightness $ Sudden difficulty in breathing and reduction in your blood pressure

$ Swelling of eyelids, face, tongue or throat

$ Lumpy skin rash, or “hives” anywhere on the body.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND

WHAT TO DO ABOUT THEM

Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and seek

immediate emergency medical attention

Only if severeIn all cases
UncommonBlurred vision or pain in he eyesT
Fast or irregular heart beatT

Difficult or

painful urination

T
RashT

Increased

wheezing or tightness in the chest or

difficulty in

breathing

(bronchospasm)

T
Swelling of the tongue or lipsT
Difficulty in swallowingT

This is not a complete list of side effects. For any unexpected effects while taking pms-IPRATROPIUM nasal spray, contact your doctor or pharmacist.

HOW TO STORE IT

Store tightly closed between 15°C and 30°C. Avoid excessive heat or freezing. Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

$ Report online at www.healthcanada.gc.ca/medeffect

$ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701E

    Ottawa, Ontario

    K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals, can be obtained by contacting Pharmascience Inc. at 1-888-550-6060.

Pharmascience Inc.

Montreal Quebec

H4P 2T4

Last revised: October 26, 2012

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02239627

Revision date stated in the text: October 26, 2012

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PMS-Ipratropium (Pharmascience, 21 mcg)

Rx or OTC
Prescription (Rx)?
DIN 02239627
Schedule(s) PRESCRIPTION
Active ingredient(s) Ipratropium bromide 21 MCG
Dosage form(s) Solution
Route(s) of administration Nasal
Drug class (WHO ATC)
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03B Other drugs for obstructive airway diseases, inhalants
        1. R03BB Anticholinergics inhalants for obstructive airway diseases
          1. R03BB01 Ipratropium bromide
Company PHARMASCIENCE INC
Current status Marketed
Current status date April 15, 1999

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.